Clearly, it is premature to suggest direct clinical applications of these findings for therapeutic target or biomarker discovery. On the contrary, actualizing the promise of translational genomics and converting academic findings into clinical applications will require a cumulative process of aggregating and jointly considering large bodies of evidence using meta-analytic and data integration techniques. Thus, it is important to rapidly disseminate genome-wide association results from longitudinal behavioral studies with genomic data, such as the GEDI samples. To facilitate this process we provide all p-values (http://www.pharmacy.vcu.edu/biomarker/resources/supplementary/) as a resource for investigators with the requisite samples to carry out replication or further meta-analysis.
